» Articles » PMID: 22672648

Apolipoprotein B/apolipoprotein A1 Ratio is a Good Predictive Marker of Metabolic Syndrome and Pre-metabolic Syndrome in Chinese Adolescent Women with Polycystic Ovary Syndrome

Overview
Date 2012 Jun 8
PMID 22672648
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The apolipoprotein B/apolipoprotein A1 (ApoB/ApoA1) ratio is well known to be related to metabolic syndrome (MS) and its components in adults of different races. There is low prevalence of MS but high occurrence of various metabolic disorders in Chinese adolescent women with polycystic ovary syndrome (PCOS). We sought to assess if the ApoB/ApoA1 ratio can be used as a predictive marker of MS and pre-MS in Chinese adolescent women with PCOS.

Material And Methods: This cross-sectional study included 160 Chinese adolescent women. Based on International Diabetes Federation criteria for MS, patients who had no less than two components of MS but did not meet the criteria for the diagnosis of MS were considered as having pre-MS.

Results: The ApoB/ApoA1 ratio was higher in obese subjects with high free androgen index (FAI). The ApoB/ApoA1 ratio increased significantly as the number of MS components increased and provided 87.5% of sensitivity and 78.9% of specificity with a threshold value of 0.63 for MS, 86.2% of sensitivity and 79.4% of specificity with a threshold value of 0.58 for pre-MS in Chinese adolescent women with PCOS.

Conclusion: The ApoB/ApoA1 ratio was a good predictive marker of MS and pre-MS in Chinese adolescent women with PCOS. FAI could be involved in obesity-related metabolic abnormalities.

Citing Articles

Risk factors for metabolic syndrome in the premetabolic state assessed using hierarchical clustering study in a health screening group.

Park S, Kim Y, Oh B, Kang J Sci Rep. 2024; 14(1):31169.

PMID: 39732771 PMC: 11682037. DOI: 10.1038/s41598-024-82513-5.


Independent association of metabolic syndrome severity score and risk of diabetes: findings from 18 years of follow-up in the Tehran Lipid and Glucose Study.

Amouzegar A, Honarvar M, Masoumi S, Agahi S, Azizi F, Mehran L BMJ Open. 2024; 14(9):e078701.

PMID: 39260837 PMC: 11409262. DOI: 10.1136/bmjopen-2023-078701.


Metabolic syndrome and adiposity: Risk factors for decreased myelin in cognitively healthy adults.

Burzynska A, Anderson C, Arciniegas D, Calhoun V, Choi I, Mendez Colmenares A Cereb Circ Cogn Behav. 2024; 5:100180.

PMID: 38162292 PMC: 10757180. DOI: 10.1016/j.cccb.2023.100180.


Menopause Predisposes Women to Increased Risk of Cardiovascular Disease.

Kaminska M, Schneider-Matyka D, Rachubinska K, Panczyk M, Grochans E, Cybulska A J Clin Med. 2023; 12(22).

PMID: 38002671 PMC: 10672665. DOI: 10.3390/jcm12227058.


Investigation of prodromal features in metabolic syndrome based on transcriptome analysis.

Park S, Park M, Ban H, Baek S, Kim S, Lee S Genes Dis. 2023; 10(3):708-711.

PMID: 37396528 PMC: 10308104. DOI: 10.1016/j.gendis.2022.07.021.